Two Forms of CCK Suppress Appetite Through the Same Liver Nerve Pathway

CCK-8 and CCK-33 both inhibited food intake through hepatic vagal afferents, with CCK-33 showing longer-lasting satiety — different CCK forms use the same pathway but with distinct temporal profiles.

Eisen, S et al.·American journal of physiology. Regulatory·2005·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-01030Animal StudyPreliminary Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Both CCK-8 and CCK-33 reduced food intake through hepatic branch vagal afferents in rats, but CCK-33 produced more sustained satiety — demonstrating shared pathway with temporal differences between CCK molecular forms.

Key Numbers

How They Did This

animal-study study on neuropeptides, gut-healing.

Why This Research Matters

Relevant for neuropeptides, gut-healing, weight-loss, receptor-signaling.

The Bigger Picture

Advances peptide research with clinical implications.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Both CCK-8 and CCK-33 reduced food intake through hepatic branch vagal afferents in rats, but CCK-33 produced more sustained satiety — demonstrating s
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2005.
Original Title:
Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation.
Published In:
American journal of physiology. Regulatory, integrative and comparative physiology, 289(2), R456-R462 (2005)
Database ID:
RPEP-01030

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Two Forms of CCK Suppress Appetite Through the Same Liver Nerve Pathway

What was found?

CCK-8 and CCK-33 both inhibited food intake through hepatic vagal afferents, with CCK-33 showing longer-lasting satiety — different CCK forms use the same pathway but with distinct temporal profiles.

Read More on RethinkPeptides

Cite This Study

RPEP-01030·https://rethinkpeptides.com/research/RPEP-01030

APA

Eisen, S; Phillips, R J; Geary, N; Baronowsky, E A; Powley, T L; Smith, G P. (2005). Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation.. American journal of physiology. Regulatory, integrative and comparative physiology, 289(2), R456-R462.

MLA

Eisen, S, et al. "Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation.." American journal of physiology. Regulatory, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Inhibitory effects on intake of cholecystokinin-8 and cholec..." RPEP-01030. Retrieved from https://rethinkpeptides.com/research/eisen-2005-inhibitory-effects-on-intake

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.